Speakers

List of speakers in alphabetical order: Pietro Ameri, Maciej Banach, Sławomir Blamek, Anna Borowiec, Giuseppe Curigliano, Susan Dent, Maciej Dyrbuś, Dimitrios Farmakis, Wojciech Fendler, Krzysztof Filipiak, Marek Gierlotka, Robert Gil, Agnieszka Gorgoń-Komor, Beata Jagielska, Barbara Alicja Jereczek-Fossa, Bartosz Krakowiak, Maciej Krzakowski, Jakub Kucharz, Bonnie Ky, Ewa Lech-Marańda, Daniel Lenihan, Teresa López-Fernández, Alexander Lyon, Raúl Córdoba Mascuñano, Peter van der Meer, Mariana Mirabel, Patrycja Ozdowska, Piotr Rutkowski, Sebastian Szmit, Aaron Sverdlov
Sebastian Szmit

Chair of the Summit on Cardio-Oncology Excellence 2025

Sebastian Szmit is a cardiologist & medical oncologist. He graduated from the Military Medical Academy in Poland (2002). From 2002 to 2012 he worked at the Military Institute of Medicine in the (1) Emergency Department, (2) Department of Internal Medicine and Cardiology, (3) Department of Oncology. Since 2012 he has been working at the Centre of Postgraduate Medical Education as: (1) a cardio-oncology consultant at the Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology (until 2022), (2) Head of the Department of Cardio-Oncology at the Institute of Hematology and Transfusion Medicine. He is a consultant of the Cardio-Oncology Subunit at the Maria Skłodowska-Curie National Research Institute of Oncology in Warsaw. He is responsible for leading the Education & Training Advisory Committee, International Cardio-Oncology Society (IC-OS). He chairs the Thrombosis Study Group of the ESC Council of Cardio-Oncology.

Beata Jagielska

Director of the Maria Skłodowska-Curie National Research Institute
 of Oncology in Poland

Teresa Lopez

Chair, ESC Council of Cardio-Oncology

Dr López-Fernández is a senior consultant cardiologist at La Paz University Hospital and the IdiPAZ Research Institute in Madrid, Spain, where she leads the Cardio-Oncology programme. She also holds this role at Quirónsalud University Hospital. Her main focus is the clinical coordination of multidisciplinary teams, cardiovascular care in patients with cancer, and advanced cardiac imaging.

She is Chair of the ESC Council of Cardio-Oncology and Co-Chair of the first ESC Guidelines on Cardio-Oncology. Previously, she founded and led the Cardio-Oncology Working Group of the Spanish Society of Cardiology (2015–2023). She also serves as Associate Editor for the European Heart Journal and European Journal of Preventive Cardiology, and sits on the editorial board of JACC: Cardio-Oncology.

Giuseppe Curigliano

President Elect of the European Society for Medical Oncology (ESMO)

Giuseppe Curigliano, MD, PhD, is the director of the Early Drug Development Division and holds the co-chair for Experimental Therapeutics Program at the European Institute of Oncology, a comprehensive cancer center in Milano, Italy. He is professor of Medical Oncology in the Department of Oncology and Hemato-Oncology at the University of Milano.  Moreover, he is member of the Italian National Health Council, serving as advisor of the Ministry of Health for cancer policy issues.

He worked at the Columbia University Comprehensive Cancer Center in New York, USA, developing an experience in preclinical and translational research. He was also visiting scholar at the Dana Farber Cancer Institute, Harvard Medical School in Boston, USA. At the European Institute of Oncology he served as Co-Director of the Division of Medical Oncology until 2014.

Professor Curigliano obtained his medical and specialist degree from the Catholic University in Rome, Italy. He is a specialist in Medical Oncology. He obtained a PhD in Clinical Pharmacology at University of Pisa, Italy.

Professor Curigliano served as an expert panel member issuing the AIOM, ESMO, ASCO guidelines in breast cancer and germline gene testing recommendations. He co-chaired for several years the scientific committee of the St Gallen Early Breast Cancer Conference. He is also a scientific board member of EUSOMA (European Society of Breast Cancer Specialists). He is serving as member of the Scientific Board of the International Breast Cancer Study Group (IBCSG). He is serving on the executive board of the Breast International Group (BIG).

In ESMO he served as Chair the ESMO Nomination Committee (2017-2019) and as Chair of the ESMO Clinical Practice Guideline Committee (2019-2023). He was one of the founding member and served as scientific Co-Chair of the “ESMO Breast Cancer Congress”. He contributed to launch the ESMO Living Guidelines and to the recognition of the Fellow of ESMO (FESMO). He organized and participated to many professional and educational programs for oncologists all over the world.

Professor Curigliano is principal investigator and steering committee member of numerous breast and early development clinical trials, particularly with innovative targeted compounds and individualized treatment strategies. His translational research focusses on the field of biomarkers and personalised therapies, biomarker discovery, development of targeted agents and implementation of personalised medicine. His team includes 40 people (including medical staff, research nurse, oncology nurse and medical oncology residents) working on basic sciences, bioinformatics, biotechnologies and clinical research. He is also leading phase I-III trials testing targeted agents in the field of breast cancer, agnostic and large national trials testing implementation of high throughput technologies in the health care system.

He has a strong interest in artificial intelligence and established in the University of Milano the first Master on Artificial Intelligence in Cancer Medicine.

Professor Curigliano was identified as Clarivate™ world’s most influential researchers (the highly cited researchers) in 2022, 2023 and 2024.  He has authored more than 800 papers in peer-reviewed journals (h-index 96) and many book chapters. He served as editorial board member for international journals in oncology (European Journal of Oncology, Journal of Clinical Oncology, Annals of Oncology).  He is a panel member of several international breast cancer consensus conferences and has served as a chair or steering committee member for numerous national and international conferences. He trained, mentored and sponsored dozens of medical oncologists from Latin America, Africa, Asia and Italy.

Professor Curigliano was awarded with the first ESO Umberto Veronesi Award (2017) and with the Fellowship of the European Academy of Cancer Sciences in Paris (2017).

Prof. Curigliano is currently serving as Editor in Chief of ESMO Open. He is ESMO President elect.

Prof. Curigliano was born in Rouyn Noranda, Canada; he is married with an intensive care doctor. He has dual citizenship (Italy and Canada).

Susan Dent

President of the International Cardio-Oncology Society (IC-OS)

Peter van der Meer

Professor Peter van der Meer, MD, PhD

Chairperson-Elect, ESC Council of Cardio-Oncology

University Medical Center Groningen, Netherlands

Peter van der Meer is a clinical cardiologist and chair of the Department of Experimental Cardiology at University Medical Center Groningen. He is also a Professor of Heart Failure and Translational Cardiology at the University of Groningen. Peter received both his MD and PhD cum laude from the University of Groningen, and completed a postdoctoral fellowship at Harvard Medical School to train his skills in stem cell biology. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics to bridge the gap between the bench and bedside. Professor van der Meer’s research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies. In 2024 he was voted by his peers as chair-elect of the Council of CardioOncology of the ESC and member of the taskforce of the ESC who wrote the first Guidelines on Cardio-Oncology. He has received funding from several agencies including the Dutch Heart Foundation, NWO, European Union H2020 program, the HFSP and has been awarded an ERC starting and ERC consolidator grant.

Bonnie Ky

Editor-in-Chief, JACC: CardioOncology

Barbara Jereczek-Fossa

President Elect of the European Society for Radiotherapy and Oncology (ESTRO)

Barbara Alicja Jereczek-Fossa, MD, PhD, is Full Professor of Radiation Oncology at UNIMI and Chair of the Radiation Oncology Department, including the Proton Center, at European Institute of Oncology, Milan, Italy. She is President Elect of ESTRO and serves on key scientific boards, including APCCC, ESO and EuropaUomo. She is PI of the AIRC-funded studies on prostate cancer, including the RADIOSA randomised phase II trial on prostate cancer oligorecurrences, the GIVE-ME-FIVE phase II study on prostate SBRT with intraprostatic boost, the GREEN Radiotherapy initiative on sustainable hypofractionation (Multilayered Urban Sustainability Action MUSA project), and the STRA-MI-VT cardiac radioablation phase I/II trial. Her research explores SBRT and hypofractionation, AI and radiomics (e.g., ESTRO-AAPM AI Guidelines, DECIDE project), proton therapy (POWER Registry) and drug radiation combinations. Author of nearly 500 publications, she holds an H-index of 58 (13.100 citations) and ranks among the Top Italian and Stanford University’s World’s Top 2% Scientists.

Alexander Lyon

Past Chairperson, ESC Council of Cardio-Oncology

Aaron Sverdlov 2

Co-Director of Newcastle Centre of Excellence in Cardio-Oncology

Institutions: University of Newcastle, Hunter New England LHD, Hunter Medical Research Institute, Calvary Mater Newcastle

Positions: Director of Heart Failure; Co-Director of Newcastle Centre of Excellence in Cardio-Oncology; Clinical Academic Cardiologist; Clinical Lead for Heart Failure and Cardio-Oncology 

Short Bio:
Aaron Sverdlov is a heart failure cardiologist and a nationally and internationally recognised leader in cardio-oncology. He is a Professor, Director of Heart Failure and Clinical Lead for Heart Failure and Cardio-Oncology at the University of Newcastle and Hunter New England Health.

 

Aaron did his undergraduate and postgraduate medical training as well as PhD in Adelaide, post-doctoral Fellowship in Boston (2012-2015) and was recruited to NSW in 2017. He is a current Heart Foundation Future Leader Fellow, and a past NHMRC CJ Martin Fellow and American Heart Association Postdoctoral Fellow. He has co-authored over 120 manuscripts (h-index 33) and obtained over $18M in grant funding.

 

Aaron co-established and co-leads Newcastle Centre of Excellence in Cardio-Oncology at the University of Newcastle, Hunter Medical Research Institute, Hunter New England Health and Calvary Mater Newcastle. This was the first internationally accredited Cardio-Oncology Centre of Excellence in the Southern Hemisphere. This multidisciplinary program incorporates fundamental discovery looking at mechanisms of cardiotoxicity, drug discovery studies, translational human research, clinical research and clinical inpatient and outpatient service delivery. His key discoveries relate to repurposing drugs to simultaneously treat cancer and protect the heart and improving cardiovascular outcomes of patients living with and beyond cancer though better models of care.

Aaron is an Associate Editor for Heart Lung and Circulation, Scientific Reports, Heart Failure Reviews and Cardiovascular Drugs and Therapy, and an international advisor for JACC CardioOncology. He is a co-founder and co-chair of the Australian Cardiovascular Alliance Cardio-Oncology Working Group, and a chair of the joint Clinical Oncology Society of Australia-Cardiac Society of Australia and New Zealand Cardio-Oncology Working Group. He is also a member of the Scientific and Research Committee and Education Committee of the International Cardio-Oncology Society and a member of the Executive for the Global Cardio-Oncology Registry, European Society of Cardiology (ESC) Cardio-Oncology Study Group and ESC Cardio-Oncology Council Study Group on Biomarkers.

Mariana Mirabel

Communications Coordinator, ESC Council of Cardio-Oncology

Dr. Mariana Mirabel, MD, PhD, is a cardiologist based in Paris, France, specialising in cardio-oncology and multimodal cardiovascular imaging. She founded the first dedicated cardio-oncology department in Paris at Hôpital Européen Georges Pompidou, affiliated with Université Paris Descartes, and now leads the cardio-oncology program at Institut Mutualiste Montsouris, providing cardiovascular care for patients from Institut Curie. Her clinical expertise focuses on the prevention and early detection of cardiotoxicity related to cancer therapies, supported by advanced imaging techniques. Dr. Mirabel is a researcher with numerous publications in the field of clinical cardio-oncology (from reverse cardio-oncology, to immune checkpoint inhibitors’ myocarditis). She serves as Communication Officer for the European Society of Cardiology’s Cardio-Oncology Council and is a core member of the Groupe de Cardio-Oncologie within the French Society of Cardiology. Fluent in French, Spanish and English, Dr. Mirabel is dedicated to advancing cardio-oncology care, education, and research both nationally and across Europe.

Pietro Ameri

Secretary, ESC Council of Cardio-Oncology

Pietro Ameri, MD, PhD, is Associate Professor in Cardiovascular Medicine and Coordinator of the PhD Program in Translational and Clinical Internal Medicine at the University of Genova, Italy. He also leads the Translational Cardiovascular research unit at IRCCS Ospedale Policlinico San Martino in Genova. He is currently Secretary of the ESC Council of Cardio-oncology and member of the HFA Scientific Committee on Basic & Translational Research. His primary interests are cardio-oncology and heart failure, including pulmonary  hypertension. Pietro Ameri’s research group includes biologists, biotechnologists and physicians and is funded by several grants.

Dimitrios Farmakis

Dimitrios Farmakis, MD, PhD, FESC, FHFA, is an Ass. Professor of Cardiology and head of the Cardio-Oncology Clinic and the Cardiac Clinic for Haemoglobinopathies at Athens University Hospital “Attikon”, National and Kapodistrian University of Athens (NKUA) Medical School, Greece. 

He graduated from the NKUA Medical School and received his doctoral degree from the same institution. He specialized in cardiology at Athens University Hospital “Attikon” and was further trained in heart failure at Zurich University Hospital, Switzerland, in cardio-oncology at Bern University Hospital “Inselspital”, Switzerland, and in clinical trials at Harvard Medical School, Boston, USA. He has been elected a fellow of the European Society of Cardiology (ESC) and a fellow of the ESC Heart Failure Association (HFA).

He has a long teaching experience at under- and post-graduate level at the NKUA, the European University Cyprus and the University of Cyprus and he is faculty of the Postgraduate Course in Heart Failure of the University of Zurich. He has further been invited as a speaker or chair to more than 350 congresses.

His research fields include heart failure, cardio-oncology and hemoglobinopathy-associated heart disease. He has published more than 350 articles, 317 of which in highly rated PubMed journals with more than 40,000 citations and an h index of 73, while he participated with more than 225 abstracts in congresses. He has further authored 72 chapters in medical textbooks and 5 complete medical textbooks. He has served as principal investigator and member of executive and steering committees in national and international trials and research projects and has received research grants and scholarships.

He sits on national and international scientific committees, guideline taskforces and expert panels. He was a member of the taskforces of the 2021 ESC Guidelines for Heart Failure, the 2022 ESC Guidelines on Cardio-Oncology, the 2023 Focused Updated of the 2021 ESC Guidelines for Heart Failure and editor of the 2021 and 2025 Thalassaemia International Federation guidelines. He is the immediate past Chairman of the ESC HFA Study Group on Cardio-Oncology, former Chairman of the ESC HFA Study Group on Atrial Disease, member of the Board and Liaison Officer of the ESC Cardio-Oncology Council, founding member and the immediate past President of the Working Group on Cardio-Oncology of the Hellenic Society of Cardiology (HSC), member of ESC Study Group on Cardiovascular Pharmacotherapy, former President of the HSC Working Group on Cardiomyopathies and Basic Research and former member of the Board and Treasurer of the Hellenic College of Cardiology. 

He has received awards from national and international organizations, such as the NKUA Medical School (first award of excellence for the doctoral thesis), University of Patras Medical School (distinguished young cardiologist award), Harvard Medical School (distinction for the capstone project proposal), American Heart Association, European Hematology Association, United Arab Emirates Government, Thalassaemia International Federation and others.

Raol Cordoba

EHA Liaison with the ESC

Associate Chief of Hematology and Head of The Lymphoma Unit and Fundacion Jimenez Diaz University Hospital, Madrid, Spain. Former European Hematology Association (EHA) Board Member. EHA Liaison with the ESC and Member of the Council of Cardio-Oncology of the European Society of Cardiology.

Dan Lenihan

Founder and Board Member, International Cardio-Oncology Society

Daniel Lenihan, MD, FACC, FESC, FIC-OS has been active in Cardio-Oncology and Heart Failure, for over 25 years. The main focus of these efforts have included hemodynamic assessments, angiogenic growth factor responses and novel cardiac biomarkers, as well as optimal methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. He has previously held positions at MD Anderson Cancer Center in Houston, Vanderbilt University in Nashville, and Washington University in St Louis.
Dr. Lenihan is at the forefront of concerted efforts to foster collaboration among a host of colleagues both regionally, nationally, and throughout the world. He is the Founder and Immediate Past President of the International Cardio-Oncology Society (IC-OS), a professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy. He is the Director of the Cardio-Oncology Center of Excellence (Gold) at Saint Francis Healthcare in Cape Girardeau, MO.

Co-Founder and Past President of the International Cardio-Oncology Society (IC-OS)

Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.

He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.

He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.

Piotr Rutkowski

President of the Polish Oncological Society

Professor Piotr Rutkowski is a renowned oncologist and surgical oncologist. He works at the Maria Skłodowska-Curie National Research Institute of Oncology in Warsaw, where he leads the Department of Soft Tissue, Bone Sarcoma, and Melanoma. His primary scientific interests include the diagnosis and treatment of melanoma and soft tissue sarcomas.

Ewa Lech-Marańda-2
Maciej Banach-1

President, International Lipid Expert Panel

Bartosz Krakowiak

Dr. Bartosz Krakowiak is Head of the Heart Failure Department at the Cardiology Clinic of the Heart Disease Center, 4th Military Clinical Hospital with Polyclinic in Wrocław, Poland. He also works in the Department of Non-Invasive Clinical Sciences, Faculty of Medicine, Wrocław University of Science and Technology.
His clinical and research interests focus on heart failure, with a particular emphasis on translating innovative therapies into clinical practice. As a principal investigator and national coordinator, he has led numerous multicenter clinical trials in collaboration with national and international partners.
He is a member of the Polish Cardiac Society, including its Heart Failure Association and Cardio-Oncology Section, and of the European Society of Cardiology.

Anna Borowiec

Anna Borowiec, PhD, MD, is a cardiologist at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland. She is the Principal Investigator of the EMPACT study (EMPAgliflozin in Prevention of Chemotherapy-Related CardioToxicity), which investigates the potential of SGLT2 inhibition to prevent cardiotoxicity in patients undergoing cancer therapy. Her clinical and research work focuses on the prevention and treatment of cancer therapy–related cardiac dysfunction (CTRCD) in oncology patients, with particular expertise in advanced cardiac imaging techniques.

Robert Gil-v2

President of the Polish Cardiac Society

Professor Robert Julian Gil, MD, Ph.D. (since 2000 the Fellow of European Society of Cardiology), a graduate of the Pomeranian Medical University in Szczecin (September 1984) has been employed since November 2001 in the Central Clinical Hospital (since January 2023 National Medical Institute) of the Ministry of the Interior and Administration of the Ministry of the Interior and Administration in Warsaw. Currently (since June 2022) as the head of the Cardiology Department created as a result of the merger of two previously operating cardiological clinics.
In 1997-2004 he was the Chair of the Invasive Cardiology Section (Working Group) of the Polish Cardiac Society, and a member of its Board (as a past president) for the next 3 years. He served as the member of the Polish Cardiac Society Board for two cadencies (2015-2019). In the elections in 2021, he was appointed president-elect of the Polish Cardiac Society (up September 2023). In October 2023 he took over as President of Polish Cardiac Society. He was also appointed as the Chair
ESC Task Force for EuroAsia in the term 2024-2026.
His scientific achievements include: over 300 publications in peer-reviewed journals (total
IF close to 800), co-authorship of over 30 chapters of books on interventional cardiology and more than 300 scientific abstracts presented at prestigious international conventions on clinical electrophysiology and invasive cardiology.
He initiated annual National Workshops on Interventional Cardiology, currently called
Warsaw Course on Cardiovascular Interventions (www.wcci.pl). Their 29 th edition was held in April
2025.
He is a member of Editorial Boards of most prestigious cardiological journals as: Polish Heart Journal, Cardiology Journal, Advances in Interventional Cardiology.
Since 2001 he has been regularly invited to actively participate (Faculty member) in such
prestigious Congresses and Workshops of Interventional Cardiology as: ESC, EuroPCR, TCT, ICI in Tel Aviv, CBS in Nanjing, European Bifurcation Club meetings and many national congresses.

Sławomir Blamek-1
Marek Gierlotka-1

President-Elect of the Polish Cardiac Society
Director of the Institute of Medical Sciences at University of Opole
Head of the Department of Cardiology at University Hospital in Opole

A specialist in cardiology, internal medicine, and intensive care, as well as an experienced interventional cardiologist. Since 2018 the Head of Department of Cardiology at University Hospital in Opole, and since 2020 the Director of the Institute of Medical Sciences at University of Opole. Co-creator and coordinator of the Polish Registry of Acute Coronary Syndromes PL-ACS and the National Database of Myocardial
Infarctions AMI-PL.
In Polish Cardiac Society currently at position of President-Elect of the Society.
As part of his activities in the European Society of Cardiology, he was a member of the Management Board of Acute Cardiovascular Care Association ACVC ESC and co-chair of the Research and Science Section (2018-2022) as well as the member of the EORP Executive Committee (2020-2022).
He received the academic title of professor of medical and health sciences in 2021. His scientific achievements include near 300 publications with a total impact factor above 700 and the Hirsh index of 31. His scientific work focuses on prevention of cardiovascular diseases as well as on epidemiology, long-term prognosis of acute cardiovascular diseases along with the analysis of the impact of the diagnostic and therapeutic process on epidemiological indicators. He serves as an expert in the field of design, implementation and analysis of clinical registries and large databases (PL-ACS, AMI-PL, SILSTROKE) as well as clinical studies.
He was awarded multiple times by the Rector of SUM and UO as well as the Polish Society of Cardiology. In 2017, he received a distinction for the project "Coordinated care after myocardial infarction" in the
"Golden Scalpel 2017" competition of Medicine Puls and was honored with the Golden Laurel of Skills and
Competences in the Medicine and Biomedical Engineering category by Chamber of Commerce and Industry in Katowice. In 2022, he was awarded by the President of the Council of Ministers for achievements in the field of scientific activity – participation in the project of creating and implementing medical registers, the analysis of which serves to optimize clinical procedures in cardiology.

Wojciech Fendler-2

President of the Medical Research Agency

Prof. Wojciech Fendler, MD, PhD (born 1982) is one of the outstanding young scientists in Poland.
He graduated from the Faculty of Medicine at the Medical University of Lodz (MUL) in 2007. He received his PhD in 2011 for his studies on proinsulin gene mutations in monogenic diabetes. He received his postdoctoral degree (habilitation) – for research on the epidemiology, pathogenesis and biomarkers of monogenic diabetes – in 2013. Subsequent studies focused on circulating miRNAs in radiation therapy and oncology. Projects conducted jointly with the Dana-Farber Cancer Institute resulted in the commercialization of an ovarian cancer diagnostic test and numerous patent applications. He received the title of professor of medicine in 2020. He authored several hundred scientific papers including numerous in renowned journals (Diabetes Care, Science Translational Medicine, Nature Communications, Cell Reports, Elife, Diabetologia, Cardiovascular Diabetology and Biomarker Research). He has led, directs or supervises more than 20 projects funded by national and EU funds, including: OPUS NCN (3x), SONATA BIS, SONATA, PRELUDIUM (7x), Pearls of Science, FIRST TEAM FNP, INTER FNP, IMPULS FNP.
Since the beginning of his scientific career, he has strived to disseminate knowledge in the field of data analysis and has supported young scientists in mastering skills crucial for independent scientific work – especially in biostatistics and scientific integrity. Prof. Fendler won multiple prestigious competitions, such as the Polpharma Foundation Scholarship, Scholarship of the Ministry of Science and Higher Education, the START FNP (2x), the ISPAD-MEDTRONIC Young Scientist Award, the Polityka Scholarship, two Awards of the Minister of Health, “Poles with Verve” and the 2020 National Science Center Award in Life Sciences. As Deputy Director for Scientific Affairs, he co-founded the Clinical Research Support Center at the MUL and directed the Doctoral School of Molecular Medicine. On July the 1 st he was appointed the President of the Medical Research Agency.

Maciej Krzakowski

National Consultant in Clinical Oncology

Specialist in medical oncology and radiotherapy. Chair of Lung Cancer and Thoracic Tumours Department at The Maria Sklodowska-Curie National Institute of Oncology in Warsaw. Chief country consultant in medical oncology since 1998 until now.
President of Polish Society of Clinical Oncology and active member of other scientific societies. Specially interested and involved in studies on combined management of cancer, development of new systemic therapies, improvement of supportive care in cancer. Author or co-author of approximately 500 full-text scientific papers published in Polish as well as international journals. Editor in chief of 35 books and manuals.

Agnieszka Gorgoń-Komor-v2

Cardiologist & Senator of the Republic of Poland

Senator of the Republic of Poland in the 10th and 11th terms, Doctor of Medical Sciences, specialist in internal medicine and cardiology, Deputy Chair of the Senate Health Committee and the Parliamentary Local Government Team, Chair of the Parliamentary Team for Scientific Research and Innovation in Healthcare, the Parliamentary Team for Cardiology, and the Parliamentary Team for Public-Private Partnership. Member of the Parliamentary Youth Team, the Senate Team for the Development of the Silesian Voivodeship, the Family, Senior and Social Policy Committee, as well as the Working Group on Obesity Prevention under the Public Health Council.

Member of the European Society of Cardiology (ESC) and the Polish Cardiac Society (PTK). For several years, she has served as President of the Beskid Branch of the Polish Medical Association.

She graduated from the Faculty of Medicine at the Jagiellonian University Medical College in Kraków. In 2019, she obtained an MBA in healthcare management.

Krzysztof Filipiak-v2

Prof. Dr hon. c. Krzysztof J. Filipiak, MD, PhD, FESC

Cardiologist & Director of the Centre of Postgraduate Medical Education

Specialist in: cardiology, internal medicine, arterial hypertension, clinical pharmacology.
Graduated at Medical University of Warsaw (MUW). Scientific and clinical internships: Utrecht, Amsterdam (the Netherlands), Milano, Catania (Italy), Rio de Janeiro (Brasil), Geneve (Switzerland); visiting professor at University of Nis (Serbia). Visiting professor: DWU University of Madang (Papua-New Guinea) and St.George’s University, Grenada. Actual affiliations: Centre of Medical Postgraduate Education (CMKP), Head; former: MUW Vice Dean for Science, Medical Faculty, MUW Deputy Rector Magnificus; MUW Medical Sciences Council Chairman Medical association memberships: Polish Cardiac Society (PCS): Chairman of Polish Top Junior Cardiologists ,,Club 30”; Co-founder and first Chairman of PCS Cardiovascular Pharmacotherapy Working Group; Polish Society of Hypertension: Past-President; International Society of Cardiovascular Pharmacotherapy (ISCP) – Governor for Poland, Directors Board Member; the Polish Academy of Science (PAS): member of PAS Clinical Sciences Committee and PAS Physiology and Pharmacology Committee; Former Editor-in-chief Kardiologia Polska [Polish Heart Journal] – the official journal of Polish Cardiac Society, Executive Editor Cardiology Journal.

Maciej Dyrbuś

Dr Maciej Dyrbuś works at the 3rd Department of Cardiology, at the Silesian Centre for Heart Diseases in Zabrze, Poland. His work focuses on cardiac implantable electronic devices, remote patient monitoring, and invasive cardiac procedures. He also presents interests in preclinical science, including the management of cardio-oncology treatment modalities in the presence of cardiac devices, being a member of a cardio-oncology team working closely with the National Oncology Institute of Maria Sklodowska-Curie, in Gliwice. During his academic years, he received a scholarship from the Polish Minister of Health for significant achievements. He holds an MD, having graduated from the Medical University of Silesia in Katowice as the best graduate, and a PhD from the same institution, having defended his thesis on the assessment of peri-mortem findings from cardiac implantable electronic devices in patients with heart failure. In 2025 he received the Golden OTIS Trust Award Scholarship in the „Scientific Debuts” category. Currently a member of the MAINSTREAM Randomized Trial Steering Committee (on behalf of the Principal Investigator). He is an Editorial Board Member of BMC Cardiovascular Disorders and European Journal of Medical Research journals.

Patrycja Ozdowska

Patrycja Ozdowska, MD, PhD is a Cardiology Consultant at the National Institute of Oncology in Warsaw and the Specialist Hospital of the Holy Family in Warsaw. She was previously affiliated with the National Institute of Cardiology in Warsaw. In her daily practice, she focuses on cardiovascular care for patients with cancer and advanced cardiac imaging. She is a member of the Polish Cardiac Society as well as the Cardio-Oncology and Echocardiography Sections.

Jakub Kucharz-1

Organisers and Partners

Patrons

Media Patron